Hopwood Financial Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
ACA
Hopwood Financial Services's XBI Position: Q4 2025 in Review
Hopwood Financial Services sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2025, closing a stake of 950 shares — an estimated $95.2K sold.
Hopwood Financial Services first reported a position in XBI in Q4 2024 and held it in 4 quarters. The position peaked at $95.2K in Q3 2025. 814 funds tracked by Wall St. Rank hold XBI as of Q4 2025.
- Hopwood Financial Services reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2025 after selling out during the quarter.
- Hopwood Financial Services sold 950 State Street SPDR S&P Biotech ETF shares in Q4 2025, an estimated $95.2K.
- Hopwood Financial Services first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and held it in 4 quarters.
- Hopwood Financial Services's State Street SPDR S&P Biotech ETF position peaked at $95.2K in Q3 2025.
- 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2025.
Based on Hopwood Financial Services's 13F filing for Q4 2025, filed 16 Jan 2026.